Ovarian Cancer Biomarker Panel (Multiplex Immunoassay)
This test measures multiple biomarkers in your blood to help detect or monitor ovarian cancer. Biomarkers are substances produced by the body that can indicate the presence of disease.
["Early detection of ovarian cancer may improve treatment outcomes."]
Key facts at a glance
- LOINC
- 78718-4
- Short code
- OBGYN Admit H&P note
- Synonyms
- OBGYN Admit H&P note
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- obstetrics-and-gynecology
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What Does This Test Measure?
This test uses a multiplex immunoassay to detect and quantify several proteins and substances linked to ovarian cancer. These may include markers like CA-125 (a common tumor marker), but the panel also assesses additional biomarkers that may provide a more comprehensive picture of ovarian cancer presence or progression.
Why Might You Need This Test?
Your healthcare provider may recommend this test if you have symptoms suggestive of ovarian cancer (e.g., persistent bloating, pelvic pain, or unexplained weight changes), a family history of ovarian cancer, or if you are at higher risk due to other medical conditions. It may also be used during follow-up for patients already diagnosed with ovarian cancer to monitor treatment effectiveness.
How Is the Test Performed?
A blood sample is drawn from a vein in your arm. The blood is then processed and analyzed in a laboratory using a specialized immunoassay technique that detects multiple biomarkers simultaneously. Results are compared to reference ranges specific to each biomarker.
What Do the Results Mean?
Results will show the levels of each biomarker measured. Elevated levels of certain biomarkers may suggest the presence of ovarian cancer, but they are not definitive on their own. Your healthcare provider will interpret the results in the context of your symptoms, medical history, and other diagnostic tests.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Short name
Ovarian Cancer Biomarker Screen
Frequently asked questions
What are the most common biomarkers tested in this panel?
Can this test replace a pelvic exam or ultrasound?
How soon will I get my results?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy